MIFH
CRDF icon

Migdal Insurance & Financial Holdings’s Cardiff Oncology CRDF Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33,064
Closed -$306K – 606
2021
Q1 		$306K Buy
33,064
+20,519
+164% +$249K ﹤0.01% 353
2020
Q4 		$226K Buy
+12,545
New +$220K ﹤0.01% 303

Other funds holding CRDF

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CRDF Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Cardiff Oncology (CRDF) in Q2 2021, closing a stake of 33,064 shares — an estimated $306K sold.

Migdal Insurance & Financial Holdings first reported a position in CRDF in Q4 2020 and held it in 2 quarters. The position peaked at $306K in Q1 2021. 90 funds tracked by Wall St. Rank hold CRDF as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Cardiff Oncology position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 33,064 Cardiff Oncology shares in Q2 2021, an estimated $306K.
  • Migdal Insurance & Financial Holdings first reported a position in Cardiff Oncology in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Cardiff Oncology position peaked at $306K in Q1 2021.
  • 90 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.